MolNFT v1 · #91818 · protein
1.8 a crystal structure of the fimx eal domain in complex with C-digmp
4FOK: “1.8 a crystal structure of the fimx eal domain in complex with C-digmp”. X-ray diffraction, 1 ligand (C2E), 1 pocket (best druggability 0.51). MolNFT v1 #91818 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4FOK
- Type
- protein
- Length
- 264 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Fimx
- UniProt
- Q8PJX9
- Ligands
- C2E
- Pockets
- 1 · best druggability 0.51
Structure
x-ray diffraction · 1 distinct chain · 49% helix, 20% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Fimx | protein | 264 | 49% helix, 20% strand | Q8PJX9 |
Ligands and binding sites
- C2E · 9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10, 12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3, 2-D:3',2'-J][1,3,7,9,2, 8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) · ligand · chains A
- GOL · Glycerol · additive · 8 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 209 | 0.51 | 0.77 | 27 | C2E, GOL |
Compared structures
- 4FOK · 1.8 A Crystal structure of the FimX EAL domain in complex with c-diGMP · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8PJX9
- Elsewhere: RCSB PDB 4FOK · PDBe 4FOK · UniProt Q8PJX9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.